ABOS — Acumen Pharmaceuticals Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-FedEx Freight, AbbVie, Intel
Acumen sinks after Alzheimer's drug fails mid-stage study
U.S. STOCKS ON THE MOVE-Symbotic, Rivian, Intel
Acumen sinks after Alzheimer's drug fails mid-stage study
Brief: Acumen Pharmaceuticals - May Offer Up To $500 Million Of Securities - SEC Filing
Acumen Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Acumen Pharmaceuticals posts smaller than expected Q3 loss
Acumen Pharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Acumen Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acumen Pharmaceuticals Q2 net loss widens, misses analyst estimates
Brief: Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million
Acumen Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview
Acumen Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: JCR Says Acumen Exercises Exclusive Option For Up To Two Alzheimer's Candidates
Brief: Acumen Pharmaceuticals Announces Nomination Of Two Enhanced Brain Delivery™ (Ebd™) Development Candidates For The Treatment Of Alzheimer’S Disease
Acumen Pharmaceuticals Q1 net loss narrows
Acumen Pharma posts smaller-than-expected 2025 loss on lower G&A costs
U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia
U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp